PerformanceResearch Phase

MGF (Mechano Growth Factor)

Intramuscular injection

Overview

Mechano Growth Factor is a splice variant of the IGF-1 gene expressed in response to mechanical stress on muscle tissue. The peptide contains a unique C-terminal domain resulting from alternative splicing that distinguishes it from systemic IGF-1.

Mechanism of Action

MGF is proposed to act locally in skeletal muscle to activate satellite cells and promote muscle fiber repair and hypertrophy following mechanical loading or injury..

Research Summary & Key Findings

Evidence derives primarily from rodent models demonstrating increased satellite cell activation and muscle regeneration following injection into damaged muscle tissue. No human clinical trials have been published, and pharmacokinetic parameters in humans remain undefined. The peptide is not approved for any medical indication.

Clinical Status

Research Phase

MGF (Mechano Growth Factor) is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.

Administration Routes

Intramuscular injection

Related Peptides in Performance

Find a Provider

Find a verified provider who offers MGF (Mechano Growth Factor) therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply MGF (Mechano Growth Factor).

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.